Status:
UNKNOWN
Cardiovascular Effects of EVOO in Healthy Reproductive-aged Women
Lead Sponsor:
University of Vermont Medical Center
Conditions:
Hypertension
Vascular Stiffness
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
This study aims to compare changes in cardiovascular function and markers of inflammation and metabolic dysfunction in women randomized to treatment with extra virgin olive oil (EVOO) versus those ran...
Detailed Description
Participants will be randomized to receive 45 ml (40 g) of extra virgin olive oil (EVOO) daily for 8 weeks or an identical dose of a control sunflower seed oil low in oleic acid and phenol content. EV...
Eligibility Criteria
Inclusion
- Women are eligible to participate if they are between the ages of 18 and 40, in good health, with regular menstrual cycles and no prior pregnancies.
Exclusion
- Routinely take medications or supplements known to affect blood pressure, heart or blood vessel function, or those with anti-inflammatory or antioxidant properties
- Smoking
- Pregnancy
- Other conditions that would impair adherence, such as allergy to olive oil or sunflower oil or difficulty swallowing
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03820336
Start Date
February 1 2019
End Date
February 1 2020
Last Update
April 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Vermont Medical Center
Burlington, Vermont, United States, 05401